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Abstract
Background Providing proper antibiotics is undoubtedly crucial to prevent infections during surgery. Objective This study 
set out to evaluate the medication administration in antibiotic prophylaxis using both quantitative and qualitative methods. 
Setting The study employed a retrospective design and observed patients who underwent surgical procedures during hospitali-
zation at a private hospital in Indonesia within the period of January–June 2019. Methods The data obtained were evaluated 
quantitatively and qualitatively; and analyzed descriptively. The quantitative evaluation used the defined daily dose (DDD) 
per 100 bed-days. The qualitative evaluation was expressed as the percentage of antibiotic suitability based on antibiotic 
administration, i.e. (1) type; (2) timing; (3) dosage; (4) duration; and (5) route. Main outcome measure Suitability of antibiotic 
prophylaxis in a hospital setting. Results There were 164 prescriptions recorded from 20 types of surgical procedures, of 
which the most common was cholecystectomy (23 patients, 14%). Most antibiotics were administered 61–120 min before the 
incision time (55 patients, 37%), and had a duration of more than 24 h (119 patients, 80%). The total DDD per 100 bed-days 
for pre-, on-, and post-surgery antibiotic use were 44.2, 33.3, and 66.7 respectively. The suitability profiles of the antibiotics 
used according to the Antibiotic Use Guideline for Hospital (2018) were as follows: 26.3% right type, 52.9% right time, 24.8% 
right dosage, 19.1% right duration, 91.8% right route, while according to American Society of Health-System Pharmacists 
Therapeutic Guidelines (2014) there were 17.6% right type, 53.4% right time, 16.4% right dosage, 19.1% right duration, 
and 96.6% right route. Conclusion Ceftriaxone was the first-choice prophylactic antibiotic administered in this Indonesian 
hospital. The data indicate a considerable non-compliance with local and international guidelines.
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Impacts on practice
• Evaluating antibiotic prophylaxis is useful for assessing 
the possibility of inappropriate antibiotic use.
• Surgeons tend to prescribe prophylactic antibiotics for all 
types of surgery despite the absence of prerequisites for 
some of them.
• Frequent inappropriate use of antibiotics can increase the 
cost of treatment and antibiotic resistance in patients.
• Increasing adherence to guidelines and the use of appro-
priate prophylactic antibiotics are important points in 
prevention of surgical site infection and control of micro-
bial resistance.
• To increase adherence, training is needed to normalize 
antibiotic selection in accordance with international and 
local guidelines.
Introduction
The National Institute for Health and Care Excellence [1] indi-
cates prophylactic antibiotics in clean, clean-contaminated, 
and contaminated surgeries, but therapeutic antibiotics for 
procedures with dirty or infected surgical wounds. Thera-
peutic antibiotics are used to eradicate or inhibit the growth 
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of suspected or proven bacteria whilst prophylactic antibiot-
ics are given to prevent infection in patients with high-risk 
procedures, and the target of their administration is to reduce 
the number of bacteria present and help the natural defenses 
of the host so that no infection occurs [2–4]. Most antibiotic 
prophylaxis, including the use of cefazolin, is recommended 
30–60 min before incision—2 h if vancomycin or a fluoroqui-
nolone is used—to ensure that the presence of antibiotics in 
serum and tissue can reach the target during the surgery [5, 6].
The Hospital National Antimicrobial Prescribing Survey 
(2020) analyzed 26,714 prescriptions from 324 hospitals in 
Australia and found that inappropriate prophylactic antibi-
otic prescriptions in surgical patients was the highest of the 
20 most common indications, such as community-acquired 
pneumonia, medical prophylaxis, cystitis, and cellulitis/
erysipelas. In that study, use of surgical prophylactic pre-
scriptions for more than 24 h decreased over six years, from 
41.1% in 2013 to 28.0%. The most common reasons for inap-
propriate prescriptions include: spectrum too broad (23.7%), 
incorrect dose or frequency (20.3%), and incorrect duration 
(20.0%) [7, 8].
Inappropriate antibiotic therapy, including excessive 
use of antibiotics, inappropriate dosages, and prolonga-
tion of therapy, potentially results in problems, such as the 
emergence of microorganisms resistant to some antibiotics. 
Antibiotic resistance makes treating the cause of infection 
increasingly difficult and causes prolonged illness, treatment, 
and hospital stay, loss of protection for patients undergoing 
surgery and other medical procedures, and increased costs 
and mortality [9–12].
The use of antibiotics in preventing infections is essen-
tial to reduce the risks associated with surgery and resist-
ance. For this reason, maximizing the quality of prophylactic 
antibiotic prescribing for surgery and antibiotic therapy (to 
treat existing infections) requires a appropriate strategy. In 
Indonesia, to control the incidence of resistance in hospitals, 
the Minister of Health has issued Regulation No. 8 (2015) 
on the Antimicrobial Resistance Control Program in Hos-
pitals [13–16]. Judicious antibiotic use includes monitoring 
antibiotic use patterns and antibiotic resistance patterns. 
As an attempt to evaluate the type and amount of antibiot-
ics, antibiotic use patterns can be assessed quantitatively 
by calculating Anatomical Therapeutic Chemical/Defined 
Daily Dose (ATC/DDD) per 100 bed-days; these patterns 
can also be determined qualitatively to evaluate the suit-
ability of antibiotic use by analyzing the appropriateness of 
indications, timing, dose, duration, and route of administra-
tion [11, 14, 15].
Aim of the study
This study was designed to evaluate the use of prophy-
lactic antibiotics in surgical patients quantitatively and 
qualitatively.
Ethics approval
This retrospective study involving human participants was 
in accordance with the ethical standards of the institutional 




The study employed a retrospective design and observed 
patients who underwent surgical procedures during hospi-
talization at a private hospital in Surabaya within the period 
of January–June 2019. Surgical procedures are commonly 
categorized by: (A) degree of urgency, (B) the seriousness of 
surgery, (C) the field of surgery, (D) type of surgery.
(A) Degree of urgency: (1) elective surgery: is a planned 
operation that can be ordered in advance as a result of a 
surgeon’s judgment. (2) emergency surgery: surgery to 
treat trauma or acute illness in patients who come to the 
emergency department, or surgery which is not planned 
for patients being treated in other ways, or patients who 
have been waiting for elective surgical procedures.
(B) The seriousness of surgery: (1) major, (2) intermedi-
ate, and (3) minor. The category is determined by the 
surgeon in the hospital. Generally: major surgeries are 
usually extensive and require overnight treatment or an 
extended stay in the hospital. These operations include 
extensive work such as entering body cavities, remov-
ing organs, or changing anatomy. Minor surgeries are 
generally superficial and do not require penetration of 
a body cavity.
(C) The field of surgery: including orthopedic, ocular, 
neurosurgery, cardiac, surgical oncology, and general 
surgery.
(D) Type of surgery: (1) clean surgery: operations per-
formed on areas without pre-surgical infection, without 
opening the tract (respiratory, gastrointestinal, urinary, 
biliary), planned surgery, or primary skin closure with 
or without the use of closed drains. (2) clean-contami-
nated surgery: operations performed on the tract (diges-
tive, biliary, urinary, respiratory, reproductive except 
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for the ovaries) or surgeries without significant con-
tamination. (3) contaminated surgery: operations that 
open the gastrointestinal tract, bile duct, urinary tract, 
airway to the oropharynx, reproductive tract except for 
the ovaries with real contamination (gross spillage) [15, 
18–20].
The inclusion criteria included patients aged ≥ 18 years who 
had complete inpatient medical records, including diagnosis, 
surgery, length of stay, name of drug, dosage, and the number 
of antibiotics used. The exclusion criteria were (1) surgical 
patients who had to undergo Intensive Care Unit (ICU) treat-
ment, (2) patients who had an infection before a surgical pro-
cedure, and (3) patients who were discharge against medical 
advice or died during the period of the study.
The use of antibiotics was classified into three stages, 
namely pre-, on-, and post-surgery. Here, pre-surgery repre-
sents the antibiotic given before the day of surgery, on-sur-
gery includes the antibiotic given on the day of surgery—i.e., 
120 min before to < 24 h after surgery, and post-surgery is 
where the antibiotic was administered > 24 h after surgery.
The use of antibiotics is classified into 0, 1, 2, 3 antibiotics 
where 0 means not using antibiotic, 1 using one antibiotic, 2 
using a combination of two antibiotics, and 3 using a combina-
tion of three antibiotics.
Data analysis
The data obtained were then evaluated quantitatively and qual-
itatively and analyzed descriptively. The quantitative evalua-
tion used the DDD per 100 bed-days, which was calculated 
using the formula below:
where DDD WHO, defined daily dose determined by WHO; 
LOS, total length of stay.
The qualitative evaluation was expressed as the percent-
age of antibiotic suitability based on antibiotic administra-
tion characteristics, namely (1) type; (2) timing; (3) dosage; 
(4) duration; and (5) route, and the comparison with Anti-
biotic Use Guideline in Hospital and American Society of 
Health-System Pharmacists (ASHP) Therapeutic Guidelines 
[6, 17, 19].
The research results were analyzed descriptively. The 
total DDD and percentage of antibiotic suitability are 
reported in tables.
Results
There were 708 surgical patients from January to June 2019, 
but only 164 patients met the inclusion and exclusion criteria 




total antibiotics (gram) × 100
DDDWHO (gram) × LOS
Meet the inclusion and exclusion criteria: 
277 patients
Do not meet the inclusion and exclusion criteria:
431 patients











Patients receiving dirty 
surgery or experiencing 
infections before surgery: 
208 patients 
Fig. 1  The flowchart of the research data collection. ICU Intensive Care Unit
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the demographic information of these patients. All patients 
had four categories of surgeries, they were divided into with 
number of groups. There were 20 types of surgical proce-
dures, of which the five most common types were cholecys-
tectomy (23 patients, 14%), herniotomy (18 patients, 11%), 
arteriovenous (AV) shunt (18 patients, 11%), appendectomy 
(17 patients, 10%), and myomectomy (14 patients, 9%). 97% 
(159) were elective surgeries, and 41% (81) were major sur-
geries. 57% (94) were rated as clean surgeries. See Table 2 
for details.  
Table 3 illustrates the profile of patients based on the 
number, timing, interval, and duration of antibiotic use. 
Most  patients (129, 79%) received a single antibiotic. 
Fifty-five patients (37%) that antibiotics were administered 
Table 1  The demographic characteristics of the research samples
Jan January, Feb February, Mar March, Apr April, Jun June, SD standard deviation, BPJS Badan Penyelenggara Jaminan Sosial (Indonesia’s 
Healthcare and Social Security Agency)
Characteristics Jan 2019 Feb 2019 Mar 2019 Apr 2019 May 2019 Jun 2019 Total %
Age (years)
18–25 3 1 4 1 1 4 14 8
26–35 7 4 4 7 8 4 34 21
36–45 6 10 8 5 6 2 37 23
46–55 8 5 10 4 3 5 35 21
56–65 4 4 3 1 4 4 20 12
≥ 65 3 5 2 6 4 4 24 15
Mean ± SD 44.61 ± 15.38 47.86 ± 13.73 42.87 ± 13.56 47.38 ± 17.13 44.92 ± 15.45 45.33 ± 18.03 45.50 ± 1.85
Total 31 29 31 24 26 23 164 100
Gender
Male 15 8 9 13 9 7 61 37
Female 16 21 22 11 17 16 103 63




Private 18 15 17 15 10 10 85 52
BPJS 13 14 14 9 16 13 79 48
Total 31 29 31 24 26 23 164 100
Table 2  Profiles of research samples based on the surgical procedure
Jan January, Feb February, Mar March, Apr April, Jun June
Characteristics Jan 2019 Feb 2019 Mar 2019 Apr 2019 May 2019 Jun 2019 Total %
Degree of urgency
Elective 31 28 29 24 26 21 159 97
Emergency 0 1 2 0 0 2 5 3
Total 31 29 31 24 26 23 164 100
The seriousness of surgery
Minor 0 8 3 0 0 0 11 7
Intermediate 11 8 14 5 9 2 49 30
Major 13 8 10 15 15 20 81 49
Complex 7 5 4 4 2 1 23 14
Total 31 29 31 24 26 23 164 100
The field of surgery
Clean 14 19 22 12 13 14 94 57
Clean-contaminated 15 9 8 12 12 9 65 40
Contaminated 2 1 1 0 1 0 5 3
Total 31 29 31 24 26 23 164 100
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Table 3  Profiles of the research samples based on the use of antibiotics
Jan January, Feb February, Mar March, Apr April, Jun June, min minutes, h hours
Characteristics Jan 2019 Feb 2019 Mar 2019 Apr 2019 May 2019 Jun 2019 Total %
Number of antibiotic uses
0 Antibiotic 3 7 3 1 0 1 15 9.15
1 Antibiotic 23 21 24 20 24 18 130 79.26
2 Antibiotics 5 1 3 3 2 4 18 10.98
3 Antibiotics 0 0 1 0 0 0 1 0.61
Total 31 29 31 24 26 23 164 100
Timing of antibiotic use
Pre surgery 0 0 0 0 0 0 0 0
On surgery 7 6 13 0 0 4 30 20
Post surgery 0 0 0 0 0 0 0 0
Pre-on surgery 0 0 0 0 0 0 0 0
On-post surgery 19 15 11 15 25 17 102 69
Pre-on-post surgery 2 2 4 8 1 0 17 11
Total 28 23 28 23 26 21 149 100
Interval of antibiotic use
0–30 min 11 4 5 7 3 5 35 24
31–60 min 4 1 5 8 7 7 32 21
61–120 min 9 10 12 6 10 8 55 37
> 120 min 4 8 6 2 6 1 27 18
Total 28 23 28 23 26 21 149 100
Duration of antibiotic use
< 24 h 7 6 13 0 0 4 30 20
> 24 h 21 17 15 23 26 17 119 80
Total 28 23 28 23 26 21 149 100
Table 4  Quantities of antibiotic 
use within the period of 
January–June 2019
DDD defined daily dose
No ATC code Antibiotics DDD per 100 bed-days Total DDD per 
100 bed-days
DDD pre DDD on DDD post
1 J01CA04 Amoxicillin – – 0.72 0.72
2 J01DB04 Cefazolin 0.74 2.82 1.55 5.11
3 J01DD01 Cefotaxime – 0.04 0.04 0.08
4 J01DD02 Ceftazidime – 0.14 – 0.14
5 J01DD04 Ceftriaxone 14.71 22.57 38.34 75.62
6 J01DD62 Cefoperazon sulbactam 12.26 3.06 10.17 25.49
7 J01DE01 Cefepime 1.47 0.14 1.45 3.06
8 J01DH02 Meropenem 14.34 1.59 4.94 20.87
9 J01GB03 Gentamicin – – 0.17 0.17
10 J01MA12 Levofloxacin – 0.14 0.64 0.78
11 J01XD01 Metronidazole 0.74 2.82 8.63 12.19
Total 44.24 33.31 66.67 144.22
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61–120 min before the incision time. Thirty patients (20%) 
that antibiotics were administered on the day of surgery only, 
102 patients (69%) that antibiotics started on the day but 
continued afterward; and 119 patients (80%) had more than 
24 h duration of antibiotics.
The total DDD per 100 bed-days for pre-, on-, and post-
surgery antibiotics use, were 44.2, 33.3, and 66.7. Table 4 
summarizes the DDD for each antibiotic used. Eleven dif-
ferent antibiotics were used in prophylaxis in this study, 
of which ceftriaxone was the most commonly used with 
75.6 DDD/100 bed-days.
Qualitatively, the percentage of suitability was evaluated 
by comparing not only the antibiotic selection but also the 
timing, dosage, duration, and route of antibiotic adminis-
tration described in Antibiotic Use Guideline Hospital and 
ASHP Therapeutic Guidelines. Table 5 presents the sum-
marized results of the suitability of the antibiotic use.
Discussion
The quantitative evaluation
The quantitative evaluation of antibiotic use using DDD/100 
bed-days as a measurement unit was intended to identify 
antibiotic use patterns: a high DDD indicates frequent anti-
biotic use. In this study, ceftriaxone was the most commonly 
used antibiotic with 75.6 DDD/100 bed-days, meaning that 
for 100 days of treatment at the hospital, about 76 patients 
received one ceftriaxone DDD daily. This figure is higher 
than a cross-sectional retrospective study that involved 
463 surgical patients at a University Hospital in Surabaya 
that found the use of ceftriaxone for prophylaxis at 21.1 
DDD/100 days of surgery [21]. The high DDD/100 bed-days 
for the administration of ceftriaxone can indicate an inap-
propriate antibiotic selection because based on ASHP Thera-
peutic Guidelines, the first-choice antibiotic for most surgi-
cal procedures in USA is cefazolin [6, 22]. However, the 
most common infecting microorganism and their resistance 
Table 5  Summary of antibiotic suitability profiles according to Antibiotic Use Guideline Hospital (2018) [19] and ASHP Therapeutic Guide-
lines (2014) [6]
AUGH Antibiotic Use Guideline Hospital ASHP American Society of Health-System Pharmacists AV arteriovenous, AFF atypical femoral frac-
tures, URS ureteroscopy, TURB transurethral resection of a bladder
Surgical procedures % right type % right time % right dose % right duration % right route
AUGH ASHP AUGH ASHP AUGH ASHP AUGH ASHP AUGH ASHP
Herniotomy (n = 18) 0 0 0 11.11 0 0 0 0 0 100
AV shunt (n = 18) 5.56 5.56 11.11 11.11 5.56 5.56 11.11 11.11 27.78 27.78
Myomectomy (n = 14) 0 0 50 50 0 0 21.43 21.43 100 100
Mammary tumor excision (n = 8) 50 50 75 75 50 50 37.5 37.5 100 100
AFF plate (n = 7) 14.29 14.29 85.71 85.71 14.29 14.29 28.57 28.57 100 100
Tumor excision (n = 7) 14.29 28.57 42.86 42.86 14.29 28.57 14.29 14.29 100 100
Soft tissue tumor excision (n = 6) 16.67 16.67 50 50 16.67 16.67 66.67 66.67 100 100
Thyroidectomy (n = 5) 100 100 80 80 100 100 60 60 100 100
Axillary tumor excision (n = 5) 0 0 20 20 0 0 0 0 100 100
Caesarean section (n = 4) 50 25 50 50 25 0 50 50 100 100
Mastectomy (n = 2) 0 0 0 0 0 0 50 50 100 100
Cholecystectomy (n = 23) 60.87 4.35 43.48 43.48 60.87 4.35 8.7 8.7 100 100
Appendectomy (n = 17) 64.71 0 41.18 41.18 58.82 0 11.76 11.76 100 100
URS (n = 9) 0 0 70 80 0 0 20 20 100 100
TURB (n = 4) 25 25 75 75 25 25 0 0 100 100
Colonoscopy (n = 4) 0 0 66.67 66.67 0 0 0 0 100 100
Hepatoscopy (n = 2) 100 100 100 100 100 100 0 0 100 100
Whipple procedure (n = 1) 0 0 0 0 0 0 0 0 100 100
Abscess drainage-incision (n = 5) 0 0 100 100 0 0 20 20 100 100
Fistulectomy (n = 4) 50 0 50 50 50 0 0 0 100 100
Post appendicitis excision (n = 1) 0 0 100 100 0 0 0 0 100 100
Average 26.26 17.59 52.91 53.38 24.79 16.4 19.05 19.05 91.8 96.56
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patterns have not been compared between Indonesia and 
the USA for all operations and this is discussed below.
Prophylactic antibiotics must have bactericidal properties 
and be effective against aerobic and anaerobic pathogens 
that are most likely to contaminate surgical areas, such as 
Staphylococcus and Streptococcus on the skin, coliforms 
(Escherichia coli and similar organisms), and normal flora 
found in the incised skin [23, 24]. Inappropriate use of pro-
phylactic antibiotics can reduce the effectiveness of anti-
biotics, increase the risk of surgical site infection, and the 
incidence of antibiotic resistance [25].
The qualitative evaluation
Choice of antibiotic
The choice of antibiotic depends on the type of surgery. 
Cholecystectomy, one of the most common procedures, 
is the surgical removal of gallstones and is classified as a 
clean-contaminated surgery. According to Antibiotic Use 
Guideline Hospital (2018), the first-choice prophylactic 
antibiotic for cholecystectomy is ceftriaxone, but ASHP 
Therapeutic Guidelines recommends cefazolin [6, 19]. 
Moazeni and Imani [26] prepared bacterial cultures from 
patients with cholelithiasis and found that the most iden-
tified microorganism was E. coli. Similarly, Soman et al. 
[27] also categorized E. coli as the most frequently isolated 
organism; the third-generation cephalosporin, ceftriaxone, is 
suitable for its effectiveness against gram-negative bacteria 
like E. coli [27]. Ceftriaxone also has a long half-life, 5–9 h, 
which means that a certain bactericidal level of antibiotic is 
sustained during a surgical procedure, and accordingly, the 
administration of additional doses for long-term surgeries 
is unnecessary [28].
Another very common surgical procedure was AV shunt 
insertion but of the 18 patients receiving it, 13 were not 
given prophylactic antibiotics. Antibiotic Use Guideline 
Hospital and ASHP Therapeutic Guidelines recommend the 
administration of cefazolin but only one patient received it. 
A retrospective study by Gray et al. [29] found that 244 of 
294 patients (83%) undergoing arteriovenous fistula (AVF) 
and arteriovenous graft (AVG) from November 2014 to July 
2016 received prophylactic antibiotics, and two of those 
patients experienced surgical site infection (0.68%) [29]. 
Since the incidence of surgical site infection in patients 
receiving and not receiving prophylactic antibiotics dur-
ing the AV Shunt procedure is not significantly different, 
most surgeons at the study hospital do not practice antibiotic 
prophylaxis for this surgery.
In this study, 18 patients (11.0%) undergoing hernia sur-
geries received prophylactic antibiotics without any indica-
tions stated in the Antibiotic Use Guideline Hospital. This 
result is 0% (0/18) in conformity to Antibiotic Use Guideline 
Hospital and ASHP Therapeutic Guidelines, respectively. 
Through a meta-analysis study, Sanchez-Manuel et  al. 
(2012) observed 7843 patients with hernias (4703 were 
given prophylactic antibiotics, but 3140 were not) and found 
that the incidence of infection occurred in 3.1% of the pro-
phylactic group and 4.5% of the control group (OR 0.64; 
95% CI 0.50–0.82) [30].
Timing of administration
Information on the right timing of antibiotic administra-
tion is essential as it can ensure that the antibiotics present 
in serum and tissue can reach the target during the surgery 
[31]. The recommended time for antibiotic use based on 
Antibiotic Use Guideline Hospital and ASHP Therapeu-
tic Guidelines is less than 60 min before the incision, or 
less than 120 min if vancomycin or fluoroquinolones are 
used [6]. Of 164 patients in this study, 52.9% conformed 
to the Antibiotic Use Guideline Hospital and 53.6% to 
ASHP Therapeutic Guidelines, with a majority of anti-
biotics administered 60–120 min before the incision (55 
patients, 37%). Inappropriate timing of antibiotics can 
increase surgical site infection, as proven in a retrospective 
cohort study by Hwan et al. (2013). They analyzed 32,459 
surgeries consisting of orthopedic, colorectal, vascular, 
and gynecological surgical procedures from 2005 to 2009 
in 112 hospitals and found that the surgical site infection 
incidence rate was higher when prophylactic antibiotics 
were administered longer than 60 min before the incision 
(OR 1.34; 95% CI 1.08–1.66) compared with an admin-
istration within 60 min before incision (OR 1.26; 95% CI 
0.92–1.72) [32].
Dosage selection
The dose of antibiotics is determined by factoring in the 
pharmacokinetic profile of antibiotics and patient condi-
tions, such as body weight, to ensure that the concentration 
of antibiotics in serum and tissue is adequate for surgical 
prophylaxis [6, 33]. According to Antibiotic Use Guide-
line Hospital, the recommended dosage varies depending 
on the type of surgical procedure, but is generally 1 g of 
ceftriaxone or 1 g of cefazolin. According to ASHP Thera-
peutic Guidelines, the recommended dosage of ceftriax-
one in adults is 2 g, or 2 g cefazolin and 3 g cefazolin for 
patients weighing ≥ 120 kg. Since the patients sampled in 
this study did not weigh ≥ 120 kg, the dose used for cefa-
zolin was 2 g [19].
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Duration of prophylaxis
Prophylactic antibiotics are given in a duration of no longer 
than 24 h, except for cardiothoracic procedures where up to 
48 h is allowable [6]. Most patients in this study (80%) used 
antibiotics for more than 24 h. There were 17 patients (11%) 
who received antibiotics from the time of admission to the 
hospital until they were about to be discharged. Seventeen 
of these patients underwent cholecysctectomy, appendec-
tomy, colonoscopy, hepatoscopy, and TURB, none of which 
required antibiotics > 24 h. Of the 149 patients who used 
antibiotics, the right duration based on the Antibiotic Use 
Guideline Hospital and ASHP Therapeutic Guidelines was 
found in 19.1% and 18.4%, respectively. Branch-Elliman 
et al. [34] observed 79,058 patients who underwent heart 
surgery, orthopedic joint replacement, colorectal surgery, 
and vascular surgery from 2008 to 2013 and found that the 
relative risks of postoperative Clostridium difficile infection 
in non-cardiac surgery where prophylactic antibiotics were 
administered for 24 to < 48 h, 48 to < 72 h, and > 72 h were 
1.31 (95% CI 1.21–1.42), 1.72 (95% CI 1.47–2.01), and 1.79 
(95% CI 1.27–2.53) compared to < 24 h [34].
Route of administration
Based on the Antibiotic Use Guideline Hospital and ASHP 
Therapeutic Guidelines, the recommended route of surgical 
prophylactic antibiotics is intravenous because it has a rapid 
onset of reaction and its levels in blood and tissue can be 
predicted [6].
Overall, this study identified inappropriate antibiotic pre-
scribing: duration (81,0%), dose (75,2%), choice of antibi-
otic (73.7%), time of giving (47.1%), and route (8.2%); com-
pared to The Hospital National Antimicrobial Prescribing 
Survey (2016) in Australia, that found improper duration 
(29.9%), wrong dosage (27.6%), and procedures that did not 
require antibiotics (22.0%) [35].
The high rate of antibiotic use that did not comply with 
the Antibiotic Use Guideline Hospital shows the lack of 
agreement between surgeons and the Antibiotic Use Guide-
line Hospital. This finding is similar to Soman et al. [27], 
who found that non-compliance with the hospital’s antibiotic 
policy was up to 50.4% [26]. Aly et al. [36] found that adher-
ence to selection, dosage, route, frequency, and duration of 
antibiotics was only 30.4%. Reasons for prescribing surgical 
prophylaxis without an approved indication included fears of 
complications, a greater confidence from the surgeon when 
the patient received antibiotics, or surgeons who disagreed 
with the guidelines [36].
Limitations
The limitation of this study lies in its retrospective design 
that collected data from available medical records. Hence, 
patients who met the inclusion and exclusion criteria but had 
incomplete medical record records had to be excluded. Also, 
inappropriate antibiotic selection may indicate that surgeons 
disagree with the current Antibiotic Use Guideline Hospi-
tal, which also refers to ASHP Therapeutic Guidelines. For 
this reason, the use of antibiotics preferred by surgeons and 
proposed by Antibiotic Use Guideline must be in agreement, 
and only then, will every surgeon comply with the Antibiotic 
Use Guideline.
Conclusion
Based on the quantity, ceftriaxone was the first-choice pro-
phylactic antibiotic administered to patients registered at a 
private hospital in Surabaya between January and June 2019 
even though often this did not conform to guidelines for the 
use of antibiotics in hospitals as well as international guide-
lines. It is necessary to carry out further research regard-
ing the factors that influence the prescribing of antibiotics 
by the surgeon and the impact of the inappropriate use of 
antibiotics.
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